Privacy Policy

Login

Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Fredag 16 Maj | 22:35:58 Europe / Stockholm

Svenska | English

BioStock

Prenumeration

Cereno Scientific: BioStock: Cereno completes CS014 trial ahead of June top-line data

2025-04-16 11:47:38

Cereno Scientific announced today the successful completion of the second and final part of its phase I clinical trial evaluating drug candidate CS014 in healthy volunteers. The milestone was marked by the last patient's last visit, and top-line results are expected in June 2025.

Read the article at biostock.se:

https://www.biostock.se/en/2025/04/cereno-completes-cs014-trial-ahead-of-june-top-line-data/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

BioStock

Prenumeration

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden